Skip to main content
Free shipping on all orders
888-559-3802
VitabaseIngredients

Avocado

Health Conditions2
Table of contents

Other Names

abacateabacateiroabokadoadpukataguacateahuacacuahuitlahuacateahuacatlalligator pearalpukatalvocaterapokaapukadoaviotaavoavocado pearavocadobaumavocadopalmeavocatieravokaavokaaavokadavokadoawokadobasholobóbatabo'butter fruitbutter pearcakutacic oncucatajcupandacuu t' p'cuytuimhedelmäavokadohuie dauLaurus perseaohohuiojokhonoupalltapaltapeaPersea americanaPersea americana var. americanaPersea americana var. drymifoliaPersea americana var. guatemalensisPersea americana var. nubigenaPersea drymifoliaPersea edulisPersea floccosaPersea giganteaPersea gratissimaPersea leiogynaPersea nubigenaPersea paucitriplinerviaPersea perseaPersea steyermarkiishamalsummer peartēpantlahtohumunyashusazabocaавокадоперсея американскаяアボカド酪梨鳄梨

Synopsis

Avocado (Persea americana Mill.)

1. Identity: Botanical Classification, Nomenclature, and Common Forms

1.1 Botanical Identity

Persea americana (commonly known as avocado, avocado pear, or alligator pear) is native to Mexico and Central America and a member of the flowering plant family Lauraceae. Botanically, the avocado fruit is a berry with a single large seed. Other synonyms of P. americana include P. gratissima, Laurus persea, P. drymifolia, and P. nubigena. Mexico is the leading producer of avocados worldwide.

The species encompasses three primary horticultural races — Mexican, Guatemalan, and West Indian — and hundreds of cultivars. The Hass cultivar, characterized by its pebbly, darkening skin, dominates global commerce. About 90% of the avocados consumed in the US, and a majority of avocados worldwide, are Hass avocados.

1.2 Common Forms and Preparations

Avocado is made available in different forms, including guacamole, chips, ice cream, frozen products, avocado paste, avocado oil, and cosmetic products. Applications of the avocado as a functional component for foods have gained outstanding interest due to its bioactive compounds such as unsaturated fatty acids, phenolic compounds, dietary fibre, vitamins B, C, and E, lutein, and various pigments including carotenoids, chlorophylls, and anthocyanins.

As a dietary supplement, avocado is most prominently used in the form of Avocado–Soybean Unsaponifiables (ASU), a concentrated extract comprising unsaponifiable fractions of one-third avocado oil and two-thirds soybean oil, used specifically in the context of joint health. Currently, the only ASU mixture investigated in clinical trials is made up of unsaponifiable fractions of one-third avocado oil and two-thirds soybean oil. Avocado oil is also available as a stand-alone culinary and cosmetic oil.


2. Traditional and Historical Use

2.1 Pre-Columbian Mesoamerica

Avocados have ancient roots and had an important place in Mesoamerican peoples' diet, mythology, and culture. It is possible that they were eaten in the Tehuacan Valley of what is now central Mexico as long as 10,000 years ago. Evidence of domesticated avocado crops has been found in Peru dating back to 750 BCE.

By 500 BCE, the avocado was known as ahuacatl to the Aztecs — the Nahuatl word for "testicle" — apparently a nod to the fact that they grow in pairs and were thought to be an aphrodisiac, or a source of strength and/or fertility to whoever consumed it. For the Aztecs, avocado was a luxurious staple. They mashed it into sauces, combined it with chili and tomatoes, or ate it with maize and beans. The predecessor of today's guacamole — derived from the Nahuatl word āhuacamōlli ("avocado mixture") — was often served during ceremonies, symbolizing abundance.

Avocado can be found as the name of the 14th month on the Maya calendar, on Pacal tombs in Chiapas, and in Aztec paintings. The Maya incorporated avocados into rituals surrounding fertility and rebirth. They consumed it fresh with corn tamales or mashed with chili and salt. Mayan healers also used avocado leaves to brew healing teas believed to ease stomach issues.

As cultures blended and met in Mesoamerica, the avocado spread widely. By the time Spaniards arrived in the Americas, "the avocado was consumed from Mesoamerica to Peru." The Aztecs are credited with introducing Spanish explorers to the avocado, and Spanish ships were responsible for transporting the fruit back to Europe and selling it to other countries.

2.2 Medicinal Uses in Traditional Contexts

While avocados themselves have gained tremendous popularity in recent years, their leaves remain a lesser-known component, holding a rich history that traces back to the Aztec and Mayan civilizations. Beyond their culinary use, avocado leaves have served as a source of wellness, flavor, and traditional medicine for centuries. Traditional uses of the whole plant — including fruit, leaves, seed, and bark — spanned the treatment of skin conditions, digestive complaints, and issues related to reproduction and fertility across Mesoamerican indigenous traditions.


3. Key Constituents and Active Compounds

3.1 Lipid Profile

The avocado pulp is notably abundant in monounsaturated fatty acids, especially oleic acid, which can comprise over two-thirds of its lipid content. In addition, it provides significant levels of dietary fiber, fat-soluble vitamins such as A, D, E, and K, carotenoids, tocopherols, and phytosterols like β-sitosterol. Avocado oils are mainly composed of monounsaturated fatty acids (76.89–84.7 g/100 g), with oleic acid (50.38–71.49 g/100 g) standing out as particularly characteristic, while β-sitosterol and α-tocopherol were among its major phytosterols and tocopherols.

3.2 Vitamins and Minerals

One-third of a medium-sized avocado (50 g) contains approximately 80 kcals, 3.4 g fiber (11% daily value), 44.5 μg folate (10% DV), 0.73 mg pantothenic acid (15% DV), 85 μg copper (10% DV), 10.5 μg vitamin K (10% DV), and 254 mg potassium (7.5% DV). One medium-sized Hass avocado provides 30% daily value vitamin K, 30% DV folate, and 45% DV pantothenic acid.

Avocado is an important contributor to the mean daily intake among consumers for beta-cryptoxanthin (33.4%), alpha-carotene (27.0%), dietary fiber (19.9%), and monounsaturated fatty acids (19.7%), and other nutrients.

3.3 Carotenoids and Xanthophylls

The carotenoids found in avocado include neoxanthin, violaxanthin, lutein-5,6-epoxide, lutein, zeaxanthin, β-cryptoxanthin, α-carotene, and β-carotene. Xanthophylls — all-trans-lutein, β-carotene, zeaxanthin, and cryptoxanthin — make up about 90% of the carotenoids in avocado. This high carotenoid content suggests that carotenoids are mainly found in the total lipids and/or amphiphilic phases of avocados. Carotenoids such as beta-carotene, lutein, and zeaxanthin are known for their potent antioxidant activity, which helps to protect cells from oxidative damage and maintain eye health.

3.4 Phenolic Compounds and Phytochemicals

Phenolic compounds of different chemical classes, from simple organic acids such as gallic acid to larger flavonoids, anthocyanidins, and tocopherols, were isolated from Persea species. The fruits contain different polyphenols including perseitol, ferulic, quinic, pantothenic, abscisic, and trans-cinnamic acids, as well as catechin.

The metabolite arsenal can be classified chemically into eight main classes, including fatty alcohols, furan derivatives, carotenoids, carbohydrates, diterpenoids, lignan derivatives, and miscellaneous compounds.

3.5 Persin

Persin is a fungicidal toxin present in the avocado. It is an oil-soluble compound structurally similar to a fatty acid — a colourless oil — that leaches into the body of the fruit from the seeds. The relatively low concentrations of persin in the ripe pulp of the avocado fruit are generally considered harmless to humans. Negative effects in humans are primarily in allergic individuals. Animal studies show that exposure to persin leads to apoptosis in certain types of breast cancer cells. It has also been shown to enhance the cytotoxic effect of tamoxifen in vitro.

3.6 Glutathione

According to the USDA, avocados contain a significantly higher amount of glutathione per average serving compared to other fruits. Glutathione is a potent tripeptide antioxidant that plays a major role in detoxification pathways and the reduction of oxidative stress and risk of cancer.

3.7 Avocado–Soybean Unsaponifiables (ASU)

Preclinical studies of ASU have shown some anti-OA properties. In vitro, ASU is seen to have an inhibitory effect on interleukin-1 (IL-1) and a stimulating effect on collagen synthesis in articular chondrocyte cultures. According to in vitro research, ASU affects the regulation of molecules related to OA, increasing structural elements like collagen and aggrecan and decreasing pro-inflammatory mediators.


4. Scientific Evidence by Area of Use

4.1 Cardiovascular Health and Lipid Modification

Overview of mechanisms: Avocados are rich in monounsaturated fatty acids (MUFAs), fiber, and plant sterols, which have cholesterol-lowering effects. Avocados are a nutrient-dense source of MUFAs and are rich in antioxidants. They have an additional LDL cholesterol (LDL-C) lowering effect beyond that observed when their MUFAs are substituted for saturated fatty acids (SFAs), especially on small, dense LDL (sdLDL) particles, which are susceptible to in vivo oxidation and are associated with increased risk of cardiovascular disease (CVD).

Meta-analyses of RCTs (2016): Ten unique studies (n = 229) were included in a meta-analysis. Avocado consumption significantly reduced total cholesterol (TC) by −18.80 mg/dL, LDL-C by −16.50 mg/dL, and triglycerides (TG) by −27.20 mg/dL. HDL-C decreased nonsignificantly by −0.18 mg/dL. Avocado-substituted diets significantly decrease TC, LDL-C, and TG levels.

Systematic review and meta-analysis (2022): Ten studies — 9 RCTs (n = 503 participants) and 1 prospective observational study (n = 55,407) — met inclusion criteria. Outcomes assessed included LDL-C (primary), TC, HDL-C, and triglycerides. Avocado consumption may reduce TC and LDL-C in people with hypercholesterolemia.

Systematic review and meta-analysis (2023): Seven RCTs were included, all reporting TC levels. Individuals who followed an avocado diet experienced reduced TC levels compared to those who followed a habitual diet or a low-fat diet. The avocado group exhibited lower TC levels in both subgroups. When considering HDL levels, findings were mixed between habitual and low-fat diet subgroups. In both subgroups, the avocado group had lower LDL levels compared to the control group. The avocado diet was associated with decreased LDL levels, but did not significantly impact triglyceride or fasting glucose levels. Systolic blood pressure values showed minimal changes with the avocado diet.

RCT — oxidized LDL (2019): A randomized, crossover, controlled feeding trial was conducted with 45 men and women aged 21–70 years with overweight or obesity and elevated LDL-C. Three cholesterol-lowering diets were provided (5 weeks each) in random sequences: a lower-fat diet and two moderate-fat diets, one of which included one avocado daily. One avocado a day in a heart-healthy diet decreased oxidized LDL (oxLDL) in adults with overweight and obesity, and the effect was associated with the reduction in sdLDL.

Evidence strength: The cardiovascular evidence is moderate to strong for lipid-modifying effects, particularly LDL-C and TC reduction in individuals with elevated lipids, supported by multiple RCTs and meta-analyses. However, the trials are heterogeneous in design and population, and larger trials looking at the impact of avocados on major adverse cardiovascular events are warranted.

4.2 Joint Health — Avocado–Soybean Unsaponifiables (ASU) and Osteoarthritis

Mechanism: According to in vitro research, ASU affects the regulation of molecules related to OA, increasing structural elements like collagen and aggrecan and decreasing pro-inflammatory mediators. Pre-clinical research in different animal models has demonstrated positive effects, such as ameliorating histopathological changes and reduced inflammation.

Systematic review of RCTs (2003/2008): Six databases were searched for randomised, placebo-controlled, double-blind trials of ASU. Four studies could be included. Their methodological quality was high. They included patients with OA of the knee and hip. The dose of ASU was 300 mg/day in most trials, and one trial also included a group treated with 600 mg/day. Three of the four trials suggested efficacy of ASU for improving the symptoms of OA.

Meta-analysis (2008): Four trials — all supported by the manufacturer — were included, with 664 OA patients with either hip (41.4%) or knee (58.6%) OA allocated to either 300 mg ASU (n=336) or placebo (n=328). Average trial duration was 6 months (range: 3–12 months). The authors concluded that ASU therapy for OA reduces pain and increases the number of patients responding to treatment. Based on the available evidence, patients may be recommended to give ASU a chance for, e.g., 3 months. Meta-analysis data support better chances of success in patients with knee OA than in those with hip OA.

Evidence strength: The evidence base for ASU in osteoarthritis is moderate for symptomatic benefit in knee OA. The authors' conclusions reflected the evidence presented but should be interpreted with a degree of caution, given the small study sizes, the small to moderate effect sizes identified, and that all included studies were industry-funded. Despite some discrepancies regarding structural changes in the joints, clinical trials typically demonstrate symptom relief and slow down disease progression. While ASU demonstrates significant promise in alleviating OA symptoms and reducing reliance on NSAIDs, further research is essential to fully understand its mechanisms of action.

4.3 Gut Microbiota and Digestive Physiology

RCT — microbiota composition (2021): Participants consumed isocaloric meals with or without avocado (175 g for men; 140 g for women) once daily for 12 weeks. The avocado treatment increased alpha diversity and enriched Faecalibacterium, Lachnospira, and Alistipes by between 26% and 65% compared with the control group. The avocado group had 18% greater fecal acetate, 70% greater stearic acid, and 98% greater palmitic acid concentrations than the control group, while concentrations of the bile acids cholic and chenodeoxycholic acid were 91% and 57% lower, respectively. Daily avocado consumption resulted in lower fecal bile acid concentrations, greater fecal fatty acid and short-chain fatty acids (SCFAs), and greater relative abundances of bacteria capable of fiber fermentation, providing evidence that this nutrient-dense food affects digestive physiology as well as the composition and metabolic functions of the intestinal microbiota.

The relative abundance of well-known butyrate producers like Clostridium leptum and Faecalibacterium prausnitzii were increased with the addition of one avocado per day to participants' usual diet.

RCT — weight loss and microbiota (2019): Daily Hass avocado consumption as part of a hypocaloric diet supported weight loss, a decrease in serum hepatocyte growth factor (HGF), and an increase in the abundance of bacteria involved in plant polysaccharide fermentation.

Evidence strength: The gut microbiota data are preliminary but mechanistically suggestive. The trials are relatively small and short-term. The clinical significance of microbiota shifts induced by avocado consumption — particularly in relation to downstream metabolic or inflammatory outcomes — remains to be established in larger trials.

4.4 Weight Management and Metabolic Health

Observational data (NHANES 2001–2008): Avocado consumers had significantly higher intakes of vegetables, fruit, diet quality, total fat, monounsaturated and polyunsaturated fats, dietary fiber, vitamins E and K, magnesium, and potassium, and lower intakes of added sugars. Body weight, BMI, and waist circumference were significantly lower, and HDL-C was higher in avocado consumers. The odds ratio for metabolic syndrome was 50% (95th CI: 0.32–0.72) lower in avocado consumers versus non-consumers.

Evidence strength (metabolic): The evidence on metabolic syndrome risk reduction is observational only at this level; confounding by overall dietary pattern cannot be excluded. While effects are modest and context-dependent, avocados represent a promising dietary component in strategies targeting obesity and type 2 diabetes.

4.5 Cancer — Preclinical and Early Clinical Data

Bioactive compounds found in avocado, such as carotenoids and xanthophylls (e.g., lutein and zeaxanthin), have demonstrated anticancer properties, particularly against tumours in the breast, larynx, and oral regions. An acetone extract of avocado pulp rich in lutein, zeaxanthin, β-cryptoxanthin, α-carotene, β-carotene, α-tocopherol, and γ-tocopherol was shown to arrest PC-3 prostate cancer cells at the G2/M phase and increase the expression of p27 protein. Ethanol extracts of avocado endocarp, seeds, whole seeds, and leaves activated transcription factor p53, caspase-3, apoptosis-inducing factor, and oxidative stress-dependent apoptosis via mitochondrial membrane depolarization in Jurkat lymphoblastic leukaemia cells.

Only one case-control study involving 243 men with prostate cancer and 273 controls in Jamaica demonstrated that MUFA from avocado may reduce the risk of prostate cancer. Bioactive compounds commonly found in avocados such as α-carotene, β-cryptoxanthin, lycopene, lutein, and zeaxanthin were found to have inverse associations with cancers of the mouth, larynx, pharynx, and breast in a few clinical trials.

Evidence strength: The anticancer evidence is predominantly preclinical (in vitro and animal studies). Human clinical evidence is very limited. No human clinical trials have directly tested avocado or its extracts as a cancer treatment.

4.6 Eye Health

Carotenoids such as beta-carotene, lutein, and zeaxanthin are known for their potent antioxidant activity, which helps to protect cells from oxidative damage and maintain eye health. Lutein and zeaxanthin are specifically concentrated in the macula of the eye and are associated in the broader nutritional literature with reduced risk of age-related macular degeneration (AMD). One practical consideration when preparing fresh avocado fruit is to scoop or scrape near the peel to retain the darker green flesh near the peel, where carotenoids are the highest.

Evidence strength: Evidence linking avocado-specific consumption to AMD outcomes in human trials is currently indirect; the existing data concern carotenoid intake broadly, not avocado specifically as an intervention.


5. Body Systems and Health Areas Associated with Avocado

  • Cardiovascular system: Lipid modification (LDL-C, TC, TG reduction); endothelial function. Supported by multiple RCTs and meta-analyses.
  • Musculoskeletal system: Symptomatic relief in knee and hip osteoarthritis via ASU preparation. Supported by several industry-funded placebo-controlled trials.
  • Gastrointestinal/microbiome: Modulation of intestinal microbial diversity and short-chain fatty acid production. Supported by preliminary RCTs.
  • Metabolic/endocrine: Associations with lower metabolic syndrome risk; potential glycemic benefits via enzyme inhibition. Human evidence largely observational.
  • Ocular health: Lutein and zeaxanthin content relevant to macular health. Evidence is indirect (carotenoid class, not avocado-specific intervention).
  • Oncology: In vitro and animal data for several cancer cell types. Human clinical evidence is absent or very limited.

6. Dosage Forms and Dosages Reported in Studies

Although the US Nutrition Labeling and Education Act (NLEA) defines the serving size of an avocado as one-fifth of a fruit (30 g), the National Health and Nutrition Examination Survey (NHANES) 2001–2006 finds that the average consumption is one-half an avocado (approximately 68 g), which provides dietary fiber (4.6 g), potassium (345 mg), magnesium (19.5 mg), vitamin C (6.0 mg), vitamin E (1.3 mg), vitamin K1 (14 μg), folate (60 μg), and lutein/zeaxanthin (185 μg), among other nutrients.

In the cardiovascular RCTs, the most commonly studied dose of whole avocado fruit was one medium avocado per day (approximately 136–200 g pulp), administered as part of a structured diet over periods of 3–12 weeks. In the gut microbiota trial, participants consumed isocaloric meals with or without avocado (175 g for men; 140 g for women) once daily for 12 weeks.

For the ASU joint health preparation: The dose of ASU was 300 mg/day in most included trials, and one trial also included a group treated with 600 mg/day. Average trial duration for ASU was 6 months (range: 3–12 months).

Among avocado consumers in a US population survey, the mean intake was 67.0 g/day.


7. Safety Considerations and Notable Interactions

7.1 General Safety in Humans

Avocado consumed as food at normal dietary quantities is well tolerated in humans. Based on current scientific understanding and extensive global consumption, avocados are considered a safe and beneficial food for humans. The relatively low concentrations of persin in the ripe pulp of the avocado fruit are generally considered harmless to humans.

7.2 Warfarin Interaction

Avocado may diminish the anticoagulant effect of warfarin. Avocado contains small to moderate amounts of vitamin K (approximately 21 mcg per 100 g of avocado), which may reduce the antithrombotic effects of warfarin. Avocado may antagonize the anticoagulant effects of warfarin; however, there has been only one case report of this interaction. This finding originates from a single case report (Blickstein et al., Lancet, 1991). The mechanism remains unclear, and the evidence base is extremely limited.

7.3 Latex–Fruit Syndrome (Allergy)

Latex fruit syndrome is a condition where individuals who are sensitive or allergic to natural rubber latex (NRL) also experience allergic reactions to certain fruits and vegetables. These fruits include banana, avocado, chestnut, kiwi, and papaya. People with natural latex allergies who consume one of these fruits can develop systemic anaphylaxis, urticaria, angioedema, and oral allergy syndrome. These fruits contain proteins structurally similar to latex, which can trigger cross-reactivity in individuals hypersensitive to latex.

Pers a 1, the major avocado allergen, is a class I chitinase — a 32 kDa heat-labile protein. This allergen cross-reacts with hevein, the principal allergen of natural rubber latex.

People who are sensitive to latex can have an allergic reaction to avocado.

7.4 Persin Toxicity — Animal Risk, Negligible Human Risk at Normal Consumption

Persin was identified as the active principle present in avocado leaves that induces lactating mammary gland necrosis of mice at a dose rate of 60–100 mg/kg; at doses above 100 mg/kg, necrosis of myocardial fibres may occur, and hydrothorax may be present in severely affected animals. Other animals affected adversely include goats, horses, and ostriches that have died of cardiomyopathy, heart failure, and respiratory distress after eating avocado leaves of Hass and Fuerte cultivars. Humans appear to lack the specific cellular targets or metabolic pathways adversely affected in sensitive animal species. The mechanism by which persin inhibits cellular respiration and damages tissues in susceptible animals does not translate to human physiology.

7.5 Infant and Pediatric Sensitivity

People sensitive to latex can have an allergic reaction to avocado. Some infants and children have a stomach allergy to milk, oat, rice, and other foods that causes vomiting and diarrhea. Eating avocado may cause the same reaction in these infants and children.

7.6 Vitamin K Content and Anticoagulant Therapy

One medium-sized Hass avocado provides 30% daily value of vitamin K. Vitamin K is vital for blood clotting, healthy bones, and other essential bodily functions. Given its notable vitamin K content, individuals using anticoagulant medications whose dosing is sensitive to dietary vitamin K intake — primarily warfarin (a vitamin K antagonist) — should maintain consistent avocado intake rather than making sudden large changes, as this could affect INR stability.


References

Health Conditions

Health conditions that Avocado may help support.

  • ArthritisScientific

    Avocado-soybean unsaponifiables (ASU) are lipid extracts from avocado and soybean oils that inhibit pro-inflammatory cytokines, stimulate collagen synthesis, and block cartilage degradation. A Cochrane-referenced systematic review (PMC4494689) found moderate-quality evidence that ASU probably improved OA pain and function, and a 2017 meta-analysis (69 RCTs) rated ASU as having 'good evidence' for OA.

  • TriglyceridesScientific

    Avocado, rich in monounsaturated fatty acids (MUFA, primarily oleic acid), beta-sitosterol, and soluble fiber, has been shown in multiple RCTs and a meta-analysis to reduce triglycerides as part of improved lipid profiles. Regular avocado consumption reduces cardiometabolic risk markers including TG.

Body Systems

Body systems that Avocado may help support.

  • No body systems available.
Join our newsletter

Stay informed. Stay healthy.

Get expert supplement tips, exclusive discounts, and product recommendations delivered to your inbox